Sickle cell disease: new pharmacological approaches

dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2016-01-28T16:56:30Z
dc.date.available2016-01-28T16:56:30Z
dc.date.created2016-01-28T16:56:30Z
dc.date.issued2012
dc.identifierBiochemistry & Pharmacology: Open Access, v. 1, n. 4, p. 1000e116, 2012.
dc.identifier2167-0501
dc.identifierhttp://hdl.handle.net/11449/133756
dc.identifier10.4172/2167-0501.1000e116
dc.identifierISSN2167-0501-2012-01-04-1000e116.pdf
dc.identifier9734333607975413
dc.identifier5737933639516944
dc.identifier0000-0003-4141-0455
dc.languageeng
dc.relationBiochemistry & Pharmacology: Open Access
dc.rightsAcesso aberto
dc.sourceCurrículo Lattes
dc.subjectSickle cell disease
dc.subjectNitric oxide
dc.subjecthalidomide
dc.subjectGammaglobin
dc.subjectHemoglobin
dc.subjectHydroxyurea
dc.titleSickle cell disease: new pharmacological approaches
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución